Risk of patients with hypertrophic cardiomyopathy undergoing noncardiac surgery

Chinese Medical Sciences Journal

Volumn 22, Issue 4, 2007, Pages 211-215

  Xuan, Tian Ming ^a   Zeng, Yong ^a   Zhu, Wen Ling ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Complications; Hypertrophic cardiomyopathy; Noncardiac surgery

Indexed keywords

ANESTHETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; INOTROPIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FATALITY; FEMALE; HEART INFARCTION; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SIDE EFFECT; SURGICAL RISK; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMEGALY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 38749094499     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nishimura RA, Holmes DR Jr. Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med 2004; 350:1320-7.
2. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardiomyopathy. Circulation 2006; 113:e858-62.
3. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42:1687-713.
4. Zipes DP, Braunwald E. Braunwald's heart disease: a textbook of cardiovascular medicine. Philadelphia: W. B. Saunders; 2005. p. 2183.
5. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287:1308-20.
6. Maron BJ, Estes NA 3rd, Maron MS, et al. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 2003; 107:2872-5.
7. Braunwald E, Seidman CE, Sigwart U. Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation 2002; 106:1312-6.
8. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006; 113:1361-76.
9. Thompson RC, Liberthson RR, Lowenstein E. Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy. JAMA 1985; 254:2419-21.
10. Haering JM, Comunale ME, Parker RA, et al. Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Anesthesiology 1996; 85:254-9.
11. Sasson Z, Yock PG, Hatle LK, et al. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 1988; 11:752-6.
12. Garcia-Miguel FJ, Serrano-Aguilar PG, Lopez-Bastida J. Preoperative assessment. Lancet 2003; 362:1749-57.
13. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39:542-53.
14. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50:e159-241.
15. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiography analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults. Circulation 1995; 92:785-9.
16. Maron BJ, Peterson EE, Maron MS, et al. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Am J Cardiol 1994; 73:577-80.
17. Cohn SL, Goldman L. Preoperative risk evaluation and perioperative management of patients with coronary artery disease. Med Clin North Am 2003; 87:111-36.
18. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004; 363:1881-91.
19. Sherrid MV. Pathophysiology and treatment of hypertrophic cardiomyopathy. Prog Cardiovasc Dis 2006; 49:123-51.
20. Roberts R, Sigwart U. Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation 2005; 112:293-6.
21. Fuster V. Hurst's the heart. New York: McGraw-Hill Health Professions Division; 2001. p. 2568.